# Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study

> **NCT04706832** · EARLY_PHASE1 · COMPLETED · sponsor: **Augusta University** · enrollment: 7 (actual)

## Conditions studied

- Diabetic Gastroparesis

## Interventions

- **DEVICE:** Thoracic Splanchnic Magnetic Neuromodulation Therapy

## Key facts

- **NCT ID:** NCT04706832
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-05
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04706832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04706832, "Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04706832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*